Multiple Sclerosis – Modus Health

PUBLICATIONS

Modus Health’s StepWatch™ has been validated in over 500 peer-reviewed publications. Its superb accuracy has StepWatch™ being used as the gold standard by researchers and companies such as Google, Fitbit, and Samsung Digital Health for measuring the accuracy of their fitness monitors.

We’re also trusted by some of the most respected research institutions in the world.

You can browse our entire publications catalog below, or use this form to download a PDF copy of our publications listing.

C. M. McDonald. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002; 81(11 Suppl):S108-20.

K. J. Nolan, M. Yarossi, A. Ramanujam. Measuring ambulation in adults with central neurologic disorders. Phys Med Rehabil Clin N Am 2013; 24(2):247-63.

P. Filipovic Grcic, M. Matijaca, I. Bilic, et al. Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients. Acta Neurol Belg 2013.

R. W. Motl, B. M. Sandroff, J. J. Sosnoff. Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis. Expert Rev Neurother 2012; 12(9):1079-88.

A. L. Schmidt, M. L. Pennypacker, A. H. Thrush, C. I. Leiper, R. L. Craik. Validity of the StepWatch Step Activity Monitor: preliminary findings for use in persons with Parkinson disease and multiple sclerosis. J Geriatr Phys Ther 2011; 34(1):41-45.

P. Filipovic Grcic, M. Matijaca, I. Lusic, V. Capkun. Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses. Med Sci Monit 2011; 17(12):CR704-10.

D. Gijbels, G. Alders, E. Van Hoof, et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 2010; 16(5):618-26.

M. E. Busse, O. R. Pearson, R. Van Deursen, C. M. Wiles. Quantified measurement of activity provides insight into motor function and recovery in neurological disease. J Neurol Neurosurg Psychiatry 2004; 75(6):884-8.

A. Neven, A. Vanderstraeten, D. Janssens, G. Wets, P. Feys. Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability. Neurol Sci 2016; 37(9):1483-90.

T. R. Brown, V. I. Simnad. A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis. Int J MS Care 2016; 18(4):170-6.